Polymorphisms in a human kidney xenobiotic transporter, OCT2, exhibit altered function
- 1 July 2002
- journal article
- research article
- Published by Wolters Kluwer Health in Pharmacogenetics
- Vol. 12 (5) , 395-405
- https://doi.org/10.1097/00008571-200207000-00007
Abstract
The completion of the Human Genome Project and the development of high-throughput polymorphism identification methods have allowed researchers to carry out full genetic analyses of many clinically relevant genes. However, few studies have combined genetic analysis within vitrophenotyping to better understand the relationship between genetic variation and protein function. Many transporters in the kidney are thought to play key roles in defense against a variety of foreign substances. The goal of this study was to understand the relationship between variation in a gene encoding a major renal xenobiotic transporter, OCT2, and transporter function. We report a comprehensive genetic analysis and functional characterization of variants of OCT2. Twenty-eight variable sites in theOCT2gene were identified in a collection of 247 ethnically diverse DNA samples. Eight caused non-synonymous amino acid changes, of which four were present at >= 1% in an ethnic population. All four of these altered transporter function assayed inXenopus laevisoocytes. Analysis of nucleotide diversity (π) revealed a higher prevalence of synonymous (π = 22.4 × 10-4) versus non-synonymous (π = 2.1 × 10-4) changes in OCT2 than in other genes. In addition, the non-synonymous sites had a significant tendency to exhibit more skewed allele frequencies (more negative Tajima'sD- values) compared to synonymous sites. The population-genetic analysis, together with the functional characterization, suggests that selection has acted against amino acid changes in OCT2. This selection may be due to a necessary role of OCT2 in the renal elimination of endogenous amines or xenobiotics, including environmental toxins, neurotoxic amines and therapeutic drugs.Keywords
This publication has 26 references indexed in Scilit:
- The legacy of pharmacogenetics and potential applicationsMutation Research - Fundamental and Molecular Mechanisms of Mutagenesis, 2001
- Transporters involved in the elimination of drugs in the kidney: Organic anion transporters and organic cation transportersJournal of Pharmaceutical Sciences, 2001
- Structure of renal organic anion and cation transportersAmerican Journal of Physiology-Renal Physiology, 2000
- Molecular mechanisms of organic cation transport in OCT2-expressing Xenopus oocytesBiochimica et Biophysica Acta (BBA) - Biomembranes, 1999
- A transfected cell model for the renal toxin transporter, rOCT2Toxicological Sciences, 1999
- Human Neurons Express the Polyspecific Cation Transporter hOCT2, Which Translocates Monoamine Neurotransmitters, Amantadine, and MemantineMolecular Pharmacology, 1998
- Cloning and Characterization of Two Human Polyspecific Organic Cation TransportersDNA and Cell Biology, 1997
- cDNA Cloning and Functional Expression of a Novel Rat Kidney Organic Cation Transporter, OCT2Biochemical and Biophysical Research Communications, 1996
- Aging and renal clearance of procainamide and acetylprocainamideClinical Pharmacology & Therapeutics, 1980
- Disposition of metformin (N,N‐dimethylbiguanide) in manClinical Pharmacology & Therapeutics, 1978